Capricor Therapeutics
CAPR
#7980
Rank
$0.29 B
Marketcap
$6.36
Share price
-4.36%
Change (1 day)
-57.82%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of September 2025 : $83.86 Million USD

According to Capricor Therapeutics 's latest financial reports the company has $83.86 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$0.14 B543.6%
2023-12-31$$22.6 M91.76%
2022-12-31$$11.78 M-62.43%
2021-12-31$$31.36 M11.23%
2020-12-31$$28.19 M312.31%
2019-12-31$$6.83 M48.18%
2018-12-31$$4.61 M-58.89%
2017-12-31$$11.22 M-380.45%
2016-12-31$-$4.01 Million287.99%
2015-12-31$-$1.04 Million-83.49%
2014-12-31$-$6.25 Million1068.24%
2013-12-31$-$0.54 Million-110.93%
2012-12-31$$4.89 M489.18%
2011-12-31$$0.83 M-68.01%
2010-12-31$$2.59 M-12.92%
2009-12-31$$2.98 M-41.57%
2008-12-31$$5.1 M-66.42%
2007-12-31$$15.19 M-11377.75%
2006-12-31$-$0.14 Million73.63%
2005-12-31$-$0.08 Million32.1%
2004-12-31$-$0.06 Million44.43%
2003-12-31$-$0.05 Million65.87%
2002-12-31$-$0.03 Million174.31%
2001-12-31$-$0.01 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Cytokinetics
CYTK
-$0.53 Billion-721.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-$6.39 Million-107.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$79.27 B 94,426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$3.00 B 3,481.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.59 B 613.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$3.57 M-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA